Key facts
- It has raised $4.4M across 1 recorded rounds; the latest was Seed Round ($1.1M) in Jun 2024.
- LevEllis has filed 1 Form D with the SEC, most recently Jun 2024 ($1.1M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for LevEllis
Funding rounds
1 roundsAbout LevEllis
Manufacturer of a skin rejuvenation platform intended to restore and maintain healthy skin function through biologically relevant repair and regeneration. The company offers a lightweight, multifunctional anti-aging facial serum built on a complete skin progenitor secretome with consistent, low-variability manufacturing, enabling dermatology and medical aesthetics stakeholders to progress from cosmetic skin improvement toward regulated medical applications with credible safety and consistency.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Asheville, NC, United States
- Founded
- 2024
- Employees
- 6
- Website
- myprovoque.com/
- Ownership
- Privately Held (backing)
LevEllis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LevEllis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LevEllis in its N-PORT filings yet. We sweep new filings monthly.